CEACAM5 and breast carcinoma: As of now there are no circulating markers for breast cancer screening or detection in clinical use, but a few such markers, e.g. carcinoembryonic antigen (CEA) or carbohydrate antigen 15-3 (CA 15-3), are being used and seem helpful for making decisions in the metastatic setting [7].